Company CVAbout Ind-Swift Laboratories Ltd 
Ind-Swift Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, India. The Company is one of the leading manufacturers of APIs catering to global and domestic formulators. Based in Chandigarh, India, the Company operated two advanced manufacturing facilities in Derabassi and Jammu, adhering to international standards. Ind-Swift Laboratories Ltd.
Company Coordinates
Company Details
SCO 850 Shivalik Enclave, NAC Manimajra Chandigarh Chandigarh ( U T ) : 160101
Registrar Details
Alankit Assignments Ltd , 205-208 , Anarkali Complex, Jhandewala Extension, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 59.09 Cr
Number of Shares
5.91 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Jan-2020
5.91
59.09
11517670
10
Debenture Conversion
08-Jan-2020
5.91
59.09
11517670
10
Debenture Conversion
24-Sep-2018
4.76
47.57
519989
10
ESOP
09-Jun-2018
4.71
47.08
1800000
10
Allotment of Equity To Others
21-Aug-2017
4.53
45.28
537631
10
ESOP
11-Nov-2016
4.47
44.74
3257166
10
Allotment of Equity Shares To Promoter & Others
11-Aug-2016
4.15
41.48
519260
10
ESOP
03-Feb-2014
4.1
40.96
1692725
10
Allotment of Equity Shares To Promoter & Others
03-Feb-2014
4.1
40.96
1692725
10
Allotment of Equity Shares To Promoter & Others
30-May-2012
3.93
39.27
10000
10
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 5 FIIs (3.0%)
Promoter with highest holding
Essix Biosciences Limited (36.83%)
Highest Public shareholder
Wilson Holdings Private Limited (8.74%)
Individual Investors Holdings
37.77%
Board of Directors
Management
Designation
Remuneration
N R Munjal
Chairman & Managing Director
1.8 cr
N R Munjal
Vice Chairman & M.D.
1.8 cr
Himanshu Jain
Joint Managing Director
1.8 cr
Pradeep Verma
Company Secretary
23.31 lacs
Rishav Mehta
Executive Director
47.9 lacs
Prabhat Khurana
Independent Director
77.5 k
S P Sharma
Independent Director
72.5 k
Neerja Chathley
Independent Director
0
Ashwani K Vig
Independent Director
65.0 k
Sahil Munjal
Executive Director
0
Rajendra Kumar Gupta
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Packing Material Consumed
3.8957
0%
Packing Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
730.93
99.95%
Traded Goods
0.36
0.05%
Pharmaceuticals
Pharmaceuticals
Traded Goods
Traded Goods
Stock DNARevenue and Profits:
Net Sales:
9 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 496 Cr (Micro Cap)
7.00
33
0.00%
-0.45
10.04%
0.52
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
